Investor Presentation • May 12, 2020
Investor Presentation
Open in ViewerOpens in native device viewer

The information contained herein in this presentation or delivered or to be delivered to you during our presentation does not constitute an offer, expressed or implied, or a recommendation to do any transaction in ICL Group Ltd. ("ICL Group" or "Company") securities or in any securities of its affiliates or subsidiaries.
This presentation and/or other oral or written statements made by ICL Group during its presentation or from time to time, may contain forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Whenever words such as "believe," "expect," "anticipate," "intend," "plan," "estimate", "predict" or similar expressions are used, the Company is making forward-looking statements. Such forward-looking statements may include, but are not limited to, those that discuss strategies, goals, financial outlooks, corporate initiatives, existing or new products, existing or new markets, operating efficiencies, or other non-historical matters.
Because such statements deal with future events and are based on ICL Group's current expectations, they could be impacted or be subject to various risks and uncertainties, including those discussed in the "Risk Factors" section and elsewhere in our Annual Report on Form 20-F for the year ended December 31, 2019, and in subsequent filings with the Tel Aviv Securities Exchange (TASE) and/or the U.S. Securities and Exchange Commission (SEC). Therefore actual results, performance or achievements of the Company could differ materially from those described in or implied by such forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can provide no assurance that expectations will be achieved. Except as otherwise required by law, ICL Group disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date hereof, whether as a result of new information, future events or circumstances or otherwise. Readers, listeners and viewers are cautioned to consider these risks and uncertainties and to not place undue reliance on such information.
Certain market and/or industry data used in this presentation were obtained from internal estimates and studies, where appropriate, as well as from market research and publicly available information. Such information may include data obtained from sources believed to be reliable, however ICL Group disclaims the accuracy and completeness of such information which is not guaranteed. Internal estimates and studies, which we believe to be reliable, have not been independently verified. We cannot assure that such data is accurate or complete.
Included in this presentation are certain non-GAAP financial measures, such as adjusted operating income, adjusted EBITDA, adjusted net income, adjusted EPS, segment EBITDA and free cash flow, designed to complement the financial information presented in accordance with IFRS because management believes such measures are useful to investors. These non-GAAP financial measures should be considered only as supplemental to, and not superior to, financial measures provided in accordance with IFRS. Please refer to our Q1 2020 press release for the quarter ended March 31, 2020 and the appendix to this presentation for a reconciliation of the non-GAAP financial measures included in this presentation to the most directly comparable financial measures prepared in accordance with IFRS.





• Strong liquidity of over \$1.1 billion in cash and available credit facilities
•Very limited impact on Q1 2020 financials
• Some impact expected in the near term
• Efficiency and cost reduction measures to mitigate COVID-19 impact

Numbers may not add due to rounding and set offs





Numbers may not add due to rounding and set offs
Adjusted EBITDA is a non-GAAP financial measure. See appendix tothis presentation for reconciliationtables. 6
Achieved record quarterlyoperating income driven by strongsales in most products

Higher salesof specialtyminerals due to high demandforfood and pharmaapplications
Signed additionallong-term contracts with Asiancustomers

(1) Segment EBITDA is a non-GAAP financial measure and is the segment profit net of depreciation and amortization. See appendix to this presentation for reconciliation tables. 7
Facilities upgrade in Q4 2019 resulted in record first quarter potash production at the DeadSea
Average realized price dropped \$44 per tonne compared to Q12019
Polysulphate production of 177 thousand tonnes, an increase of 34% over Q12019

Potash production in Spain resumed after about three weeks of shutdown and is currently at 60% capacity and rampingup
Post quarter signing of potash supply contracts with our customers in China for 910 thousand tonnes and an option for additional 490 thousandtonnes

(1) Segmented EBITDA is a non-GAAP financial measuresand is segment profit net of depreciation andamortization. See appendix to this presentation for reconciliation tables. 8
Continued focus on Phosphate Specialties growth partially compensated for a 30% declinein commodity phosphate prices
Solid performance for YPH JV inChina despite impact ofCOVID-19

Strong demand for phosphate fertilizers reflected in highersales volumes
Strong demand for food andother phosphatespecialties
Post quarter divestment of Hagesud followingstrategicdecisiontodivest lowsynergybusinesses

(1) Segmented EBITDA is a non-GAAP financial measure. See appendix to this presentation for reconciliation tables. Segment profit net of depreciation and amortization
Decrease in sale of third-party products contributed to valueover volumestrategy

Continued sales growthin emergingmarkets
Completed acquisition of US-based precision agriculture company, Growers Holdings,Inc.

10 (1) Segmented EBITDA is a non-GAAP financial measure. See appendix to this presentation for reconciliation tables. Segment profit net of depreciation and amortization




| \$ millions |
Q1 2020 |
Q1 2019 |
% change |
Q4 2019 |
% change 19% |
|
|---|---|---|---|---|---|---|
| Sales | 1,319 | 1,415 | (7%) | 1,106 | ||
| Operating income | 132 | 227 | (42%) | 88 | 50% | |
| Adjusted EBITDA(1) |
250 | 350 | (29%) | 201 | 24% | |
| Netincome | 60 | 139 | (57%) | 48 | 25% | |
| EPS (Presented in US\$) |
0.05 | 0.11 | (55%) | 0.04 | 25% | |
| Operating cash flow |
166 | 173 | (4%) | 212 | (22%) |
1.Adjusted EBITDA is a non-GAAP financial measure. See appendix to this presentation for reconciliationtables.


Source: CRU Fertilizer Historical Prices April 30 2020
GMOP CFRBrazil GTSP CFRBrazil

| \$ millions |
Q12020 | |||
|---|---|---|---|---|
| Liabilities(1) | 2,684 | |||
| Interestrate | 4.0% | |||
| Interest expenses |
26 | 30 | ||
| Interest capitalization |
(5) | (4) | ||
| Interest expenses, net |
21 | 26 | ||
| Total hedging transactions, balance sheet revaluation & | other | 44 | (7) | |
| Interest & exchange rate impact on long-term liabilities leasing and employees |
of | (13) | 16 | |
| Net financial expenses |
52 | 35 | ||
| Exchange rate impact (\$ million) |
Q1'20 vs.Q1'19 | Main currency |
||
| Sales Operating income |
(16) (12) |

Numbers may not add due torounding 1.Average liabilities during the given quarter
Main currency Depreciation of the Euro against the US\$ Appreciation of ILS against theUS\$

Total cash balance as of March 31, 2020amounts to \$524million

Available creditfacilities as of March 31, 2020 amounts to \$590million
1.Net debt to adjusted EBITDA is calculated as short term credit + long term debt & debentures – cash & cash equivalents – short term investments & deposits, divided by last twelve months adjusted EBITDA. Adjusted EBITDA is a non-GAAP measure. See reconciliation table in the appendix for thispresentation 2.Not including ~\$300 million leasing liability due to implementation of IFRS16 accountingstandard 3.Excluding securities and creditfacilities

Gross debt as ofMarch 31, 2020: \$2.6bn(2)

Differentiated business model and growth of specialty products provides a strong foundation
Expectations for improving commodity price environment and continued growth of specialty business despite short-term headwinds

Significant liquidity profile and no significant near-term principal repayments ensures flexibility to manage and opportunistically grow the business















Numbers may not add due to rounding and set offs.








| \$ millions | 01 2020 | 01 2019 |
|---|---|---|
| Adjusted income before tax(1) | 81 | 206 |
| Normalized tax rate | 21% | 2196 |
| Normalized tax expenses | 17 | 44 |
| Carryforward losses not recorded for tax purposes | 2 | |
| Exchange rate impact and other items | l | 9 |
| Adjusted tax expenses | 20 | 154. |
| Adjusted Effective tax rate | 25% | 26% |
| Tax adjustments | 3 | |
| Reported provision for income taxes | 20 | 51 |

Adjusted operating income(1)
Finance expenses
Share in earnings (losses) of equity-accounted investees and adjustments to financial expenses
Adjusted income before tax
| Calculation of segment EBITDA | Industrial Products | Potash | Phosphate Solutions | IAS | ||||
|---|---|---|---|---|---|---|---|---|
| Q12020 Q12019 Q12020 Q12019 Q12020 Q12019 Q12020 Q12019 | ||||||||
| Segment profit | 103 | 97 | 14 | 79 | O | 35 | 14 | 13/ |
| Depreciation & Amortization | 17 | 16 | 39 | 39 | 49 | 43 | 5 | 5 |
| Segment EBITDA | 120 | 113 | 53 | 118 | 58 | 781 | 19 | 18 |
Numbers may not add due to rounding
See detailed reconciliation table in the Q1 2020 PR

| 206 81 |
|
|---|---|
| ----------- | -- |

| Calculation of adjusted EBITDA Q1 2020 Q4 2019 Q3 2019 FY 2019 FY 2019 FY 2018 FY 2017 | F2016 | |||||||
|---|---|---|---|---|---|---|---|---|
| Net income attributable to the | 60 | 48 | 130 | 158 1 | 475 | 1 364 | (122) | |
| shareholders of the Company | 1,240 | |||||||
| Depreciation and Amortization | 118 | 113 | 110 | 109 | 443 | 403 | 390 | 401 |
| Financing expenses, net | 52 | 25 | 32 | 37 | 129 | 158 | 124 | 132 |
| Taxes on income | 20 | 15 | 35 | 4.6 | 147 | 1999 | 158 | 55 |
| Adjustments(1) | (10) | 기 | (766) | 23 | 585 | |||
| Adjusted EBITDA | 250 | 201 | 307 | 340 | 1,198 | 1,164 | 1,059 | 1,051 |
| Adjusted EBITDA | 250 | 1 201 | 307 | 340 | 1,198 | 1,160 | 904 9 968 |
| Calculation of Net debt to adiusted EBITDA(2) | 01 2020 FY 2020 FY 2018 FY 2017 FY 2016 | ||||
|---|---|---|---|---|---|
| Net debt | 2.435 | 2.4107 | 2,212 | 3,037 | 3,268 |
| Adjusted EBITDA | 1,098 | 1,198 | 1,164 | 1,059 | 1,051 |
| Net debt to adjusted EBITDA | 2.22 | 220 | 119 | 29 | B.IV |
Numbers may not add due to rounding

We disclose in this Quarterly Report non-lead operating income, adjusted net income attributable to the Company's shareholders, adjusted EPS and free cash flow. Our managenent uses such facilitate perating nerformance comparisons from period to period and present free cash flow to facilitate review of our cash flows in periods. We calculate our adjusting our operating income to ad certain items, as set och above and in the reconciliation table "Mijustments to reported operating and net income". Certain of these items of adjusted net income attributable to the Company's shareholders by adjusting our adjusted operating income, net income attributable to the Conpany's shareholders, as set forth above and in the reconcliation table "Adjustments or reported operating and net income (Non-GAP)" in the accompanying ress release, excluding the total adjustments and adjustments attributable to the non-controlling interests. We calculate our adjusted EBTDA by adding back to the adjusted operating income the depection. Adjusted PS is calculated net income divided by weighted average diluted number of ordinary of ordinary of ordinary outdanding a provided in the reconcliation of Adjusted EPS". We calculate our segment EBTDA by adding back to our segment profit the deprect. We calculate our free cash flow as our cash flow it is net of our purchase of property, plant, equipment and intangible assets, and adding Proceeds from sale of property, plant and dividends from equity accounted in research in the resorciliation table under "Caculation of free cash flow" You should not iev adjusted operating income, adjusted net income attributable to the edited EBTDA as a substitute for operating income or net income or net income attributable to the Company's shareholders determined in accordance with FRS, adjustitute for EPS of free cash flow as a substitute and cash flows substinc activities, and your hat our definitions of adjusted net income attributable to the Company's shareholders, adjusted EBTDA and free cash flow may differ from those used by other conpanies. However, we believe that such information to both management and investors by excluding certain expenses that maragenert believes are not indicative of our organisms. In particular or Caper to include any Proceeds from sale of property, plant and equipment because we believe such anounts offeet the inpact of our purchand intangible assets. Ile further adjust free cash flow to add Dividents from equity accounted investes because receipt of such dividends affects our residual cash flow does not reflect adjustment for additional items that may impact our residual cash flow for discretionary expericles, a quistments for charges relating to aquisitions, changes in our deposit account balances that relate to our investing activities and other non-discetionary expenditures. Our nanagement uses hese non-lFRS measures and management's performance. Weblieve that these non-FFS measure provide useful information to investors because they improve the comparability of the between periods and provide for greater transparency of key measures used to evaluate our performance. We present a discussion in the period comparisons of changes in the company's results of operations. This discussion's based in part on management's best estimates of the impact of the maint in its businesses. Ne have a sur financial statements. You should read the fiber in the many of the with our financial statements.










Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.